CVR number 42363960
Industry 86.9030 Other human health activities

Psykolog Mille Karnøe ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.0% 0.0% 6.9% 3.9% 3.2%  
Credit score (0-100)  0 0 33 50 55  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 321 196 370  
EBITDA  0.0 0.0 166 62.0 195  
EBIT  0.0 0.0 166 62.0 195  
Pre-tax profit (PTP)  0.0 0.0 166.3 61.4 193.2  
Net earnings  0.0 0.0 128.0 47.8 150.3  
Pre-tax profit without non-rec. items  0.0 0.0 166 61.4 193  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 168 216 306  
Interest-bearing liabilities  0.0 0.0 0.5 0.5 0.5  
Balance sheet total (assets)  0.0 0.0 259 309 413  
Net Debt  0.0 0.0 -82.3 -103 -92.3  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 321 196 370  
Gross profit growth  0.0% 0.0% 0.0% -39.0% 88.7%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 259 309 413  
Balance sheet change%  0.0% 0.0% 0.0% 19.6% 33.5%  
Added value  0.0 0.0 166.3 62.0 194.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 51.8% 31.6% 52.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 64.3% 21.8% 54.0%  
ROI %  0.0% 0.0% 98.7% 32.2% 74.6%  
ROE %  0.0% 0.0% 76.2% 24.9% 57.6%  

Solidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 64.9% 69.7% 74.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -49.5% -165.9% -47.5%  
Gearing %  0.0% 0.0% 0.3% 0.2% 0.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 5.7% 106.9% 361.1%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 4.9 3.8 5.5  
Current Ratio  0.0 0.0 4.9 3.8 5.5  
Cash and cash equivalent  0.0 0.0 82.8 103.3 92.8  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 206.3 220.4 330.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 195  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 195  
EBIT / employee  0 0 0 0 195  
Net earnings / employee  0 0 0 0 150